Today: 16 May 2026
Woodside Energy stock ends week up as Scarborough milestone and oil jump set up next trade
31 January 2026
1 min read

Woodside Energy stock ends week up as Scarborough milestone and oil jump set up next trade

Sydney, Jan 31, 2026, 17:12 AEDT — The market has closed.

  • Shares of Woodside Energy Group Ltd climbed on Friday, boosted by stronger crude oil prices.
  • Investors face a tough call: Scarborough’s project delivery versus a volatile oil outlook for 2026.

Shares of Woodside Energy Group Ltd (WDS.AX) ended Friday at A$25.37, marking a 0.8% gain from the previous close. The Australian market was closed on Saturday.

The stock’s recent strength hinges on two key factors: a rise in oil prices and new details about Scarborough, its upcoming major Australian growth venture. Since Woodside’s cash flow depends heavily on oil and LNG (liquefied natural gas) prices, shifts in crude tend to impact its share price fast.

Crude takes center stage again as the next session begins, with investors zeroing in on the near-term calendar. Woodside has set its annual report and investor briefing for Feb. 24.

Oil topped $70 a barrel late January as traders factored in geopolitical risks. OPEC+ is set to meet Sunday, with delegates hinting the group will maintain its March output freeze.

A Reuters poll conducted this week among economists and analysts still forecasts a market surplus in 2026 despite ongoing geopolitical tensions. Norbert Ruecker, head of economics & next generation research at Julius Baer, said, “The oil market appears to be in a lasting surplus.” Reuters

Woodside reported that the floating production unit for the Scarborough project, an offshore gas processing facility, has safely reached the field—a key milestone. The project stands 94% complete, with first LNG cargo still scheduled for the fourth quarter of 2026, the company confirmed.

The stock has climbed roughly 5% since closing on January 23, buoyed by a string of daily gains in the last week of the month.

That surge tightens the margin for mistakes. A dip in geopolitical tensions might ease crude prices, and the widely anticipated 2026 oversupply could drag down oil-related stocks if prices fall closer to the $60 range.

Execution remains a key challenge. Scarborough still faces hook-up and commissioning tasks; any delays or rising costs could disappoint investors eager for fresh volume.

Woodside investors will be watching Sunday’s OPEC+ meeting and early-week oil moves closely. The next big company event arrives on Feb. 24, when Woodside is set to release its full-year results along with updated guidance.

Stock Market Today

  • Boeing Shares Fall 3.7% Amid Mixed Analyst Ratings and Insider Selling
    May 15, 2026, 7:22 PM EDT. The Boeing Company (NYSE:BA) shares dropped 3.7% to $220.63 on Friday, with trading volume rising 26% above the daily average. Despite recent analyst upgrades-including ratings of 'buy' and target prices up to $295-Boeing's stock price fell below its 50- and 200-day moving averages. The aerospace giant reported better-than-expected quarterly earnings of -$0.20 per share versus estimates of -$0.68, with revenue up 14% year-over-year to $22.22 billion. Insider selling was noted as EVP Uma M. Amuluru sold 1,503 shares valued at $351,371. Boeing holds a market capitalization of $173.92 billion and a consensus analyst rating of 'Moderate Buy,' reflecting cautious optimism amid volatility.

Latest articles

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

NextNRG Q1 Revenue Gains, but Company Holds Cash Warning

16 May 2026
NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

16 May 2026
HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
BofA 7-Eleven ATM Settlement Opens, Deadline June 29 for Former Clients

BofA 7-Eleven ATM Settlement Opens, Deadline June 29 for Former Clients

16 May 2026
Bank of America agreed to pay $2.25 million to settle claims it charged duplicate balance-inquiry fees at FCTI-owned ATMs in 7-Eleven stores. Former account holders must file claims by June 29; current customers will receive automatic credits if the court approves the deal. Final approval is set for Aug. 21 in San Diego federal court. The class period covers May 2018 to November 2021.
SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

16 May 2026
SpaceX plans to list on Nasdaq as early as June 12 under the ticker SPCX, seeking to raise about $75 billion at a $1.75 trillion valuation, sources told Reuters. The company aims to publish its prospectus next week, with investor meetings set for June 4. Bloomberg reported Brookfield has already placed a $2 billion bet ahead of the IPO. SpaceX’s filing includes supervoting shares and strict limits on shareholder proposals.
Abbott stock jumps 3% into the weekend as Wall Street resets targets after earnings wobble
Previous Story

Abbott stock jumps 3% into the weekend as Wall Street resets targets after earnings wobble

Lynas Rare Earths share price sinks as U.S. steps back from critical-minerals price floors
Next Story

Lynas Rare Earths share price sinks as U.S. steps back from critical-minerals price floors

Go toTop